Skip to main content
Filing year 2024

SCLERODERMA CLINICAL TRIALS CONSORTIUM INC

Boston, Massachusetts·EIN 04-3543489·NTEE H99 · Medical Research·3
Total revenue
$326k
Total assets
$4M
Total expenses
$299k
Reported officers
4
Mission

TO FOSTER SCIENTIFIC RESEARCH AND TO ADVANCE MEDICAL RESEARCH IN THE FORM OF TREATMENT TRIALS IN SCLERODERMA ON A WORLDWIDE BASIS.

Reported officers (all unpaid)

No paid executives reported in 2024. SCLERODERMA CLINICAL TRIALS CONSORTIUM INC reported 4 unpaid officers and board members on its 990.

President
Vice Preside
Treasurer
Secretary
Financial trend

Revenue and expenses over time

SCLERODERMA CLINICAL TRIALS CONSORTIUM INC reported revenue and expenses across 2 filing years.

RevenueExpenses
$264k
$210k
2023
$326k
$299k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Medical Research executives earn in Massachusetts

SCLERODERMA CLINICAL TRIALS CONSORTIUM INC reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in Massachusetts earns a median of $183,768.

25th percentile
$102k
Median
$183,768
75th percentile
$307k
90th percentile
$481k

These are medical research sector-wide figures, not this organization's reported pay. Based on 74 organizations across 74 filings (2022 – 2024).

See full Medical Research pay data for Massachusetts
FAQ

Common questions about SCLERODERMA CLINICAL TRIALS CONSORTIUM INC

What are SCLERODERMA CLINICAL TRIALS CONSORTIUM INC's revenue and expenses?

In 2024, SCLERODERMA CLINICAL TRIALS CONSORTIUM INC reported $326k in total revenue and $299k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.